Evil Knievil: Emollient cream

By
1 mins. to read
Evil Knievil: Emollient cream

I am indebted for what follows on AMYT as an investment idea to Robert Corden, formerly of Charles Stanley and before that firm became a marketing organisation fronted by brain dead salesmen. About 1 in 20,000 people are born with an appalling skin condition, I think known as Epidermis Bulosa (EB), which causes great pain and does not heal. Amryt (LON:AMYT) has come up with a cream which has come sailing through its first extensive trials where – and this is very important – the patients wish to go on taking/using this cream. Apparently, it took one father five hours to wash his young daughter and alleviate the pain as much as possible.

It is possible that this will be on sale by the end of March 2021 and start off with annual sales of $200m giving a profit of after tax of £100m. Given that the market exceeds $1bn it can be seen that in a year or two’s time AMYT will be making a sum vastly in excess of its current capitalisation of 200p per share of £300m. This is an investment to hold for some years and could easily see the shares past £10. Even in a bear market.

*****

If any reader can access the organising committee of BLM he/she might point out that the poor blacks of independent Africa are ruled by all black kleptocrats, and as a result are seriously deprived of what is rightfully theirs. Indeed, these poor people are frequently compelled to emigrate to north Africa and then, if they can, to Europe. Frequently they are drowned in the Mediterranean. This must stop: after all, Black Lives Matter.

*****

I won £50,000 on Galileo Chrome on Saturday in the St Leger. This could yet prove to be a very good horse.


Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *